newsfilter
← Earnings
Earnings Releases·

Revvity — Q3 2026 Earnings Summary

Revvity reported third-quarter 2026 revenue of $729 million, representing a 7% pro forma organic growth rate. The company posted adjusted earnings per share of $1.38 from continuing operations and raised its full-year 2026 guidance to forecast pro forma adjusted EPS between $5.40 and $5.45. Life Sciences revenue grew 11% pro forma, while Diagnostics revenue increased 4% pro forma for the quarter. The company also announced an upcoming Investor Day scheduled for November 13, 2026.

Company
REVVITY INC
Sector
Healthcare
Industry
Diagnostics & Research